$Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction$

Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction

Abstract Aims The study sought to comprehensively investigate the effect of heart failure (HF) pharmacotherapies in patients with HF with mildly reduced ejection fraction (HFmrEF). In the absence of randomized controlled trials, guideline recommendations concerning HF-related therapies in patients w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of preventive cardiology 2024-08, Vol.31 (11), p.1347-1360
Hauptverfasser:	Schupp, Tobias, Bertsch, Thomas, Reinhardt, Marielen, Abel, Noah, Schmitt, Alexander, Lau, Felix, Abumayyaleh, Mohammad, Akin, Muharrem, Weiß, Christel, Weidner, Kathrin, Behnes, Michael, Akin, Ibrahim
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Aged Aged, 80 and over Angiotensin-Converting Enzyme Inhibitors - therapeutic use Cardiovascular Agents - adverse effects Cardiovascular Agents - therapeutic use Female Heart Failure - drug therapy Heart Failure - mortality Heart Failure - physiopathology Humans Male Middle Aged Mineralocorticoid Receptor Antagonists - therapeutic use Patient Readmission Retrospective Studies Risk Assessment Risk Factors Sodium-Glucose Transporter 2 Inhibitors - adverse effects Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Stroke Volume - drug effects Time Factors Treatment Outcome Ventricular Function, Left - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!